Shares of UltraTech Cement are in focus today, April 28 after the company reported fourth quarter results on Monday. The cement maker's net pofit grew 20.2% to Rs 2,983 crore in fourth quarter of fiscal 2026 from Rs 2,482 crore in the same period previous year. Revenue rose 11.9% to Rs 25,799 crore in Q4FY26 from Rs 23,063 crore in Q4FY25. EBITDA was up 21.3% at Rs 5,600 crore for the quarter ended on March 31, 2026 compared to Rs 4,618 crore in Q4FY25. Additionally, EBITDA margin touched 21.7% from 20%.
In additon to results, UltraTech Cement declared final interim dividend of Rs 240 per equity share with a face value of ₹10 each for the year ended 31st March, 2026, subject to approval of the members at the ensuing Annual General Meeting (AGM). The total aggregate outflow for UltraTech Cement on account of dividend for the year will be Rs 7,072.30 crore.
Jefferies' maintained a 'Buy' rating and raised its target price to Rs 14,050, marking 16.9% upside from last closing price of Rs 12,010. The brokerage flagged that current financial year will be tougher amid cost headwinds, while UltraTech may traget EBITDA growth thourgh price hikes. Meanwhile, Morgan Stanley reiterated 'Overweight' coverage at a target price of Rs 14,600, citing cost efficiency measures.
Jefferies on UltraTech
- The brokeregar maintained 'Buy', hiked target price to Rs 14,050.
- The results were a solid close to FY26, managing FY27 cost headwinds
- FY27 will be tougher year amid cost headwinds
- Company may still target YoY EBITDA/T growth via price hikes and cost savings
Morgan Stanley on UltraTech
- Morgan Stanley maintained 'Overweight'; at a target price of Rs 14,600.
- Another quarter of volume market share gains, cost efficiency, and economies of scale.
- UltraTech is a preferred cement player for its strong earnings compounding story
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.